Clinical Trials Directory

Trials / Completed

CompletedNCT01335503

Effect of AN-PEP Enzyme on Gluten Digestion

Effect of AN-PEP Enzyme on Gastrointestinal Breakdown of Gluten

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
12 (actual)
Sponsor
DSM Food Specialties · Industry
Sex
All
Age
18 Years – 44 Years
Healthy volunteers
Accepted

Summary

The aim is to demonstrate how fast and to what extent AN-PEP can degrade gluten in vivo in the stomach and how much gluten enters the small intestine. A second question is whether the caloric density of a meal can influence the efficacy of AN-PEP breakdown.

Detailed description

In this trial, the effect of AN-PEP enzyme on gastrointestinal breakdown of gluten will be investigated in healthy subjects. In addition, it will be assessed if meal calories can affect the efficacy of AN-PEP. Subjects receive intragastrically, either AN-PEP or placebo, with either a high or a low caloric meal in a double-blind, randomized, placebo-controlled, cross-over fashion. Gastrointestinal fluid will be sampled to measure breakdown of gluten.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTAN-PEPEndoprotease enzyme (AN-PEP)

Timeline

Start date
2011-04-01
Primary completion
2012-05-01
Completion
2012-05-01
First posted
2011-04-14
Last updated
2013-08-13

Locations

1 site across 1 country: Netherlands

Source: ClinicalTrials.gov record NCT01335503. Inclusion in this directory is not an endorsement.